North America Molecular Point Of Care Diagnostics Market Forecast 2019-2028

North America Molecular Point Of Care Diagnostics Market Forecast 2019-2028

KEY FINDINGS
The North America molecular point of care diagnostics market estimated to record growth, registering a CAGR of 14.50% during the forecast period, 2019-2028. Many diagnostics manufacturers are prioritizing their portfolio expansion and are partnering with service providers and pharmaceutical market players. The region houses numerous established and emerging organizations that utilize hereditary and genomic headways for creating new demonstrative tests and advancements. Such factors are impacting the growth of the market.

MARKET INSIGHTS
The North America molecular point of care diagnostics market growth analysis entails the market assessment of Canada and the United States. Many initiatives have been undertaken by the US government for developing precision drugs and tests for oncology and non-oncology diseases, like the funding of new start-ups in molecular diagnostics and precision medicine domains. Canada is facing growing demands for rapid and multiplex diagnostics at low costs. Numerous public and private initiatives are projected to hasten the growth of the Canadian market, along with the availability of sexually transmitted disease diagnostics like HIV, CT-NG, and HPV. But, there are market growth restraints like a limited point of care policy, variability in market evaluation, unclear point of care regulatory pathway, etc. Overall, the North America market is benefited by the opportunities in clinical diagnostics research facilities, which is due to the development of advanced biomarker-based molecular diagnostic tests.

COMPETITIVE INSIGHTS
Some of the eminent companies operating in the market include, Abacus Diagnostica, Biocartis NV, Abbott Laboratories, Luminex Corporation, Hologic Inc, etc.
Our report offerings include:
• Explore key findings of the overall market
• Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
• Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
• Market Segmentation cater to a thorough assessment of key segments with their market estimations
• Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
• Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
• Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
• Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments


1. Research Scope & Methodology
1.1. Study Objectives
1.2. Scope Of Study
1.3. Methodology
1.4. Assumptions & Limitations
2. Executive Summary
2.1. Market Size & Estimates
2.2. Market Overview
3. Market Dynamics
3.1. Market Definition
3.2. Key Drivers
3.2.1. Demand From Governments For Diagnosing Covid-19 Positive Patients
3.2.2. Rise In Demand For Non-invasive Diagnosis
3.2.3. Growth In The Number Of Diseases
3.2.4. Funding For Research And Development
3.2.5. Technological Advancements In The Market
3.3. Key Restraints
3.3.1. High Capital Requirement
3.3.2. Lack Of High Complexity Testing Centers
4. Key Analytics
4.1. Key Investment Insights
4.2. Porter’s Five Force Analysis
4.2.1. Buyer Power
4.2.2. Supplier Power
4.2.3. Substitution
4.2.4. New Entrants
4.2.5. Industry Rivalry
4.3. Opportunity Matrix
4.4. Vendor Landscape
4.5. Regulatory Framework
5. Market By Technology
5.1. Polymerase Chain Reaction
5.1.1. Real Time Pcr
5.1.2. Digital Pcr
5.2. Isothermal Nucleic Acid Amplification Technology
5.3. Other
6. Market By Product
6.1. Assays
6.2. Instruments
6.3. Software
7. Market By Application
7.1. Infectious Disease
7.1.1. Respiratory
7.1.2. Hospital Acquired Infections
7.1.3. Sexually Transmitted Infections
7.1.4. Gastro Intestinal Infections
7.2. Oncology
7.3. Prenatal
7.4. Others
8. Market By End-user
8.1. Hospitals
8.2. Clinics
8.3. Diagnostics Centres
8.4. Others
9. Geographical Analysis
9.1. North America
9.1.1. United States
9.1.2. Canada
10. Company Profiles
10.1. Abbott Laboratories
10.2. Abacus Diagnostica
10.3. Biomérieux Sa
10.4. Biocartis Nv
10.5. Danaher Corporation
10.6. Diasorin Spa
10.7. Bio-rad
10.8. F Hoffmann-la Roche Ag
10.9. Luminex Corporation
10.10. Hologic Inc
10.11. Mesa Biotech
10.12. Spartan Biosciences Inc
10.13. Quantumdx Group Ltd
10.14. Quidel Corporation
10.15. Qiagen Nv

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook